Clinical Trials Directory

Trials / Completed

CompletedNCT04254575

Understanding Daily Changes in BDD Risk Using Smartphones

Smartphone-based Digital Phenotyping to Detect High-risk Affect States in Body Dysmorphic Disorder (BDD)

Status
Completed
Phase
Study type
Observational
Enrollment
87 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD. This study aims to use smartphone-based digital phenotyping to develop and validate unobtrusive, time-sensitive, and ecologically valid measures of key risk factors for suicide and substance misuse in BDD: negative affect states. As next steps, this research can be extended to detect risk transdiagnostically, with the goal of enabling just-in-time interventions to target suicide and substance misuse across psychiatric illnesses.

Conditions

Interventions

TypeNameDescription
OTHERNone, observational study only (no interventions)None, observational study only (no interventions)

Timeline

Start date
2020-07-15
Primary completion
2023-04-28
Completion
2023-04-28
First posted
2020-02-05
Last updated
2023-09-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04254575. Inclusion in this directory is not an endorsement.

Understanding Daily Changes in BDD Risk Using Smartphones (NCT04254575) · Clinical Trials Directory